Galectin Therapeutics Inc.

Historical 13F Holders

Symbol
GALT
CUSIP
363225202
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 363225202 since 12/18/2024, largest first.

Filer % of Class Filed
Richard E. Uihlein 13D/A 49.3% 8/4/2026
Event 7/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 38 3.11 M $12.0M
2026 Q2 101 15.8 M $73.5M
2026 Q1 101 13.9 M $38.8M
2025 Q4 99 11.6 M $48.1M
2025 Q3 85 10.4 M $44.0M
2025 Q2 89 10.5 M $22.2M
2025 Q1 97 10.4 M $12.7M
2024 Q4 104 10.1 M $13.0M
2024 Q3 86 9.78 M $26.9M
2024 Q2 74 9.76 M $22.2M
2024 Q1 61 7.99 M $19.1M
2023 Q4 68 7.41 M $12.3M
2023 Q3 61 9.07 M $17.4M
2023 Q2 61 7.28 M $10.5M
2023 Q1 61 7.17 M $15.1M
2022 Q4 62 7.29 M $8.25M
2022 Q3 61 6.94 M $11.3M
2022 Q2 62 7.06 M $9.26M
2022 Q1 63 7.47 M $12.0M
2021 Q4 59 7.50 M $15.5M
2021 Q3 72 7.29 M $28.2M
2021 Q2 78 7.92 M $25.3M
2021 Q1 77 9.94 M $22.7M
2020 Q4 81 10.9 M $24.3M
2020 Q3 75 10.1 M $26.9M
2020 Q2 77 10.2 M $31.1M
2020 Q1 79 9.68 M $19.0M
2019 Q4 80 10.6 M $30.3M
2019 Q3 81 9.39 M $34.4M
2019 Q2 79 9.26 M $38.4M
2019 Q1 67 7.30 M $37.3M
2018 Q4 62 6.02 M $20.8M
2018 Q3 64 6.03 M $36.2M
2018 Q2 71 5.60 M $35.6M
2018 Q1 64 4.99 M $23.6M
2017 Q4 50 3.74 M $12.5M
2017 Q3 50 3.89 M $8.30M
2017 Q2 52 3.98 M $9.79M
2017 Q1 47 3.72 M $8.55M
2016 Q4 45 2.86 M $2.80M
2016 Q3 47 3.04 M $3.43M
2016 Q2 52 3.50 M $8.82M
2016 Q1 50 3.50 M $5.01M
2015 Q4 58 3.60 M $9.98M
2015 Q3 52 2.66 M $7.02M
2015 Q2 58 3.33 M $9.08M
2015 Q1 62 4.07 M $13.6M
2014 Q4 62 3.76 M $13.0M
2014 Q3 64 4.41 M $22.2M
2014 Q2 66 4.32 M $59.7M
2014 Q1 55 3.54 M $53.9M